Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

200 mg itraconazole, given orally as 20 mL × 10-mg/mL solution BID on Day 15, followed by QD dosing on Days 16 through 23, inclusive.

600 mg rifampin, given orally as 2 × 300-mg capsules QD on Days 15 through 25, inclusive.

0.5 mg KBP-5074, given orally as 1 × 0.5-mg tablet on Days 1 and 19 or Days 1 and 21